Selective pulmonary pulsatile perfusion with oxygenated blood during cardiopulmonary bypass attenuates lung tissue inflammation but does not affect circulating cytokine levels

European Journal of Cardio-thoracic Surgery

Volumn 42, Issue 6, 2012, Pages 942-950

  Santini, Francesco ^a   Onorati, Francesco ^a   Telesca, Mariassunta ^b   Menon, Tiziano ^a   Mazzi, Paola ^c   Berton, Giorgio ^c   Faggian, Giuseppe ^a   Mazzucco, Alessandro ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b CA FONCELLO HOSPITAL   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Cardiopulmonary bypass; Cytokines; Inflammation; Lung injury; Pulmonary perfusion; Pulsatile flow

Indexed keywords

GAMMA INTERFERON; GROWTH REGULATED ONCOGENE ALPHA; INTERLEUKIN 1; INTERLEUKIN 18; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; LEUKOCYTE COUNT; LUNG ALVEOLUS OXYGEN TENSION; LUNG LAVAGE; LUNG PERFUSION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL COUNT; PNEUMONIA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SELECTIVE PULSATILE PULMONARY PERFUSION;

AGED; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; LUNG; MALE; MIDDLE AGED; PERFUSION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PULMONARY ALVEOLI; TREATMENT OUTCOME;

EID: 84873142227     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs199     Document Type: Article

References (25)

1. Ng CS, Hui CW, Wan S, Wan IY, Ho AM, Lau KM et al. Lung ischaemia-reperfusion induced gene expression. Eur J Cardiothorac Surg 2010;37:1411-20.
2. Massoudy P, Zahler S, Tassani P, Becker BF, Richter JA, Pfauder M et al. Reduction of pro-inflammatory cytokine levels and cellular adhesion in CABG procedures with separated pulmonary and systemic extracorporeal circulation without an oxygenator. Eur J Cardiothorac Surg 2000;17:729-36.
3. Schlensak C, Doenst T, Preuber S, Wunderlich M, Kleinschmidt M, Beyersdorf F. Cardiopulmonary bypass reduction of bronchial blood flow: a potential mechanism for lung injury in a neonatal piglet model. J Thorac Cardiovasc Surg 2002;123:1199-205.
4. Sievers HH, Freund-Kaas C, Eleftheriadis S, Fischer T, Kuppe H, Kraatz EG et al. Lung protection during total cardiopulmonary bypass by isolated lung perfusion: preliminary results of a novel perfusion strategy. Ann Thorac Surg 2002;74:1167-72.
5. Tsuchida M, Watanabe H, Watanabe T, Hirahara H, Haga M, Ohzeki H et al. Effects of cardiopulmonary bypass on cytokine release and adhesion molecule expression in alveolar macrophages. Preliminary report in six cases. Am J Respir Crit Care Med 1997;156:932-8.
6. Santini F, Onorati F, Telesca M, Patelli F, Berton G, Franchi G et al. Pulsatile pulmonary perfusion with oxygenated blood ameliorates pulmonary hemodynamic and respiratory indices in low-risk coronary artery bypass patients. Eur J Cardiothorac Surg 2011;40:794-803.
7. Densem CG, Hutchinson IV, Yonan N, Brooks NH. Influence of IFN-gamma polymorphism on the development of coronary vasculopathy after cardiac transplantation. Ann Thorac Surg 2004;77:875-80.
8. Santini F, Onorati F, Faggian G, Mazzucco A. Reply to Bingyang et al. Eur J Cardiothorac Surg 2011;40:1553.
9. Kotani N, Hashimoto H, Sessler DI, Muraoka M, Wang JS, O'Connor MF et al. Neutrophil number and interleukin-8 and elastase concentrations in bronchoalveolar lavage fluid correlate with decreased arterial oxygenation after cardiopulmonary bypass. Anesth Analg 2000;90:1046-51.
10. Angus DC, Clermont G, Linde-Zwirble WT, Musthafa AA, Dremsizov TT, Lidicker J et al.; NO-06 Investigators. Healthcare costs and long-term outcomes after acute respiratory distress syndrome: a phase III trial of inhaled nitric oxide. Crit Care Med 2006;34:2883-90A.
11. Asimakopoulos G, Smith PLC, Ratnatunga CP, Taylor KM. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg 1999;68:1107-15.
12. Goebel U, Siepe M, Mecklenburg A, Doenst T, Beyersdorf F, Loop T et al. Reduced pulmonary inflammatory response during cardiopulmonary bypass: effects of combined pulmonary perfusion and carbon monoxide inhalation. Eur J Cardiothorac Surg 2008;34:1165-72.
13. Ng CSH, Wan S, Arifi AA, Yim APC. Inflammatory response to pulmonary ischemia-reperfusion injury. Surg Today 2006;36:205-14.
14. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002;21:232-44.
15. Chapelier A, Reignier J, Mazmanian M, Detruit H, Dartevelle P, Parquin F et al. Pentoxifylline and lung ischemia-reperfusion injury: application to lung transplantation. Universitè Paris-Sud Lung Transplant Group. J Cardiovasc Pharmacol 1995;25:S130-3.
16. Steimle CN, Guynn TP, Morganroth ML, Bolling SF, Carr K, Deeb GM. Neutrophils are not necessary for ischemia/reperfusion lung injury. Ann Thorac Surg 1992;53:64-72.
17. Mills AN, Hooper TL, Hall SM, McGregor CG, Haworth SG. Unilateral lung transplantation: ultrastructural studies of ischemia-reperfusion injury and repair in the canine pulmonary vasculature. J Heart Lung Transplant 1992;11:58-67.
18. Geudens N, Vanaudenaerde BM, Neyirinck AP, Van De Wauwer C, Rega FR, Verleden GM et al. Impact of warm ischemia on different leukocytes in bronchoalveolar lavage from mouse lung: possible new targets to condition the pulmonary graft from the non-heart-beating donor. J Heart Lung Transplant 2006;25:839-46.
19. Tikkanen J, Lemstrom K, Halme M, Pakkala S, Taskinen E, Koskinen P. Cytological monitoring of peripheral blood, bronchoalveolar lavage fluid, and transbronchial biopsy specimens during acute rejection and cytomegalovirus infection in lung and heart-lung allograft recipients. Clin Transplant 2001;15:77-88.
20. De Perrot M, Young K, Imai Y, Liu M, Waddell TK, Fischer S et al. Recipient T-cells mediate reperfusion injury after lung transplantation in the rat. J Immunol 2003;171:4995-5002.
21. Burke DL, Frid MG, Kunrath CL, Karoor V, Anwar A, Wagner BD et al. Sustained hypoxia promotes the development of a pulmonary arteryspecific chronic inflammatory microenvironment. Am J Physiol Lung Cell Mol Physiol 2009;297:238-50.
22. Kunz LI, Lapperre TS, Snoeck-Stroband JP, Budulac SE, Timens W, van Wijngaarden S et al., Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease Study Group. Smoking status and antiinflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD. Resp Res 2011;22:12-34.
23. Yamada H, Mizuno S, Ross AC, Sugawara I. Retinoic acid therapy attenuates the severity of tuberculosis while altering lymphocyte and macrophage numbers and cytokine expression in rats infected by mycobacterium tuberculosis. J Nutr 2007;137:2696-700.
24. Philippidis P, Athanasiou T, Nadra I, Ashrafian H, Haskard DO, Landis RC et al. Anti-inflammatory haemoglobin scavenging monocytes are induced following coronary artery bypass surgery. Eur J Cardiothorac Surg 2010;37:1360-6.
25. Staton GW, Williams WH, Mahoney EM, Hu J, Chu H, Duke PG et al. Pulmonary outcomes of off-pump vs on-pump coronary artery bypass surgery in a randomized trial. Chest 2005;127:892-901.